• Testing GSK5764227 combined with standard cancer treatments in patients with advanced solid tumors to evaluate safety and effectiveness

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Pyridoxal Phosphate for Treatment of Seizures in Patients with PNPO Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    Poland

  • A Study of AZD4512 Alone or With Other Cancer Drugs for People With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Comparing Two Treatment Lengths of Cetuximab, Avelumab, Cisplatin, and Docetaxel for Patients with Returning Spread Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A Study of Gilteritinib to Eliminate Remaining Cancer Cells in Patients with Acute Myeloid Leukemia and FLT3-ITD Mutation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece

  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Recruiting

    1 1 1
    Germany Spain

  • Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Finland +10

  • A Study of Idecabtagene Vicleucel CAR-T Cell Therapy for Patients with Autoimmune Diseases That Did Not Respond to B Cell Removal Treatment

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece Italy Poland Portugal Romania Slovakia +1

  • Testing two moisturizing creams with urea, propylene glycol, and propylene glycol alone for preventing flare-ups in patients with atopic dermatitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway Sweden

powered by